Literature DB >> 32430461

Lack of efficacy of hydroxychloroquine in covid-19.

Joseph M Vinetz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32430461     DOI： 10.1136/bmj.m2018

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.

Authors:  Enrico Scala; Luca Fania; Filippo Bernardini; Rodolfo Calarco; Sabrina Chiloiro; Cristiana Di Campli; Sabrina Erculei; Mauro Giani; Marzia Giordano; Annarita Panebianco; Francesca Passarelli; Andrea Trovè; Sofia Verkhovskaia; Giandomenico Russo; Antonio Sgadari; Biagio Didona; Damiano Abeni
Journal:  Immun Inflamm Dis       Date:  2021-05-04

Review 2.  Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.

Authors:  Zhihong Zuo; Ting Wu; Liangyu Pan; Chenzhe Zuo; Yingchuo Hu; Xuan Luo; Liping Jiang; Zanxian Xia; Xiaojuan Xiao; Jing Liu; Mao Ye; Meichun Deng
Journal:  Front Pharmacol       Date:  2021-02-08       Impact factor: 5.810

3.  Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2.

Authors:  Xia Xiao; Conghui Wang; Ying Wang; Xiaojing Dong; Tao Jiao; Zhendong Zhao; Lili Ren; Charles S Dela Cruz; Lokesh Sharma; Xiaobo Lei; Jianwei Wang
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

4.  Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response.

Authors:  Lu Zhao; Hao Liu; Yingchao Wang; Shufang Wang; Dejin Xun; Yi Wang; Yiyu Cheng; Boli Zhang
Journal:  Engineering (Beijing)       Date:  2021-11-15       Impact factor: 7.553

5.  How COVID-19 changed clinical research strategies: a global survey.

Authors:  Annina Bauer; Anja Eskat; Atara Ntekim; Creany Wong; Deborah Eberle; Elham Hedayati; Fabian Tay; Henry Yau; Louise Stockley; María de Medina Redondo; Selçuk Şen; Silvia Egert-Schwender; Yağız Üresin; Regina Grossmann
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

6.  Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on EudraVigilance data.

Authors:  Domenico Motola; Giulia Bonaldo; Nicola Montanaro
Journal:  Fundam Clin Pharmacol       Date:  2022-05-08       Impact factor: 2.747

7.  Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.

Authors:  Suvojit Hazra; Alok Ghosh Chaudhuri; Basant K Tiwary; Nilkanta Chakrabarti
Journal:  Life Sci       Date:  2020-07-15       Impact factor: 6.780
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.